Citadel Advisors
IRMD icon

Citadel Advisors’s iRadimed IRMD Stock Holding History

Citadel Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.13M Sell
32,504
-23,254
-42% -$2.33M ﹤0.01% 5185
2025
Q4 		$5.42M Buy
55,758
+22,031
+65% +$1.89M ﹤0.01% 4173
2025
Q3 		$2.4M Buy
33,727
+30,320
+890% +$2.02M ﹤0.01% 5697
2025
Q2 		$204K Buy
+3,407
New +$187K ﹤0.01% 10642
2025
Q1 		– Sell
-5,304
Closed -$292K – 15009
2024
Q4 		$292K Buy
+5,304
New +$279K ﹤0.01% 9713
2024
Q3 		– Sell
-17,750
Closed -$780K – 14716
2024
Q2 		$780K Sell
17,750
-14,003
-44% -$596K ﹤0.01% 7103
2024
Q1 		$1.4M Buy
31,753
+11,527
+57% +$509K ﹤0.01% 6228
2023
Q4 		$960K Buy
20,226
+2,695
+15% +$113K ﹤0.01% 6769
2023
Q3 		$778K Sell
17,531
-16,346
-48% -$760K ﹤0.01% 7105
2023
Q2 		$1.62M Sell
33,877
-18,383
-35% -$829K ﹤0.01% 5544
2023
Q1 		$2.06M Buy
52,260
+37,115
+245% +$1.35M ﹤0.01% 5317
2022
Q4 		$428K Buy
+15,145
New +$433K ﹤0.01% 8564
2022
Q2 		– Sell
-5,617
Closed -$252K – 13472
2022
Q1 		$252K Buy
+5,617
New +$260K ﹤0.01% 10977
2021
Q4 		– Sell
-7,086
Closed -$238K – 14276
2021
Q3 		$238K Buy
+7,086
New +$241K ﹤0.01% 11585
2020
Q4 		– Sell
-12,610
Closed -$270K – 11210
2020
Q3 		$270K Sell
12,610
-11,118
-47% -$250K ﹤0.01% 8313
2020
Q2 		$550K Buy
23,728
+3,682
+18% +$79K ﹤0.01% 6912
2020
Q1 		$428K Buy
+20,046
New +$477K ﹤0.01% 6721

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors's IRMD Position: Q1 2026 in Review

Citadel Advisors reduced its iRadimed (IRMD) stake by 42% in Q1 2026, selling an estimated $2.33M and leaving 32,504 shares worth $3.13M. The position accounts for ﹤0.01% of the portfolio, ranked #5185.

Citadel Advisors first reported a position in IRMD in Q1 2020 and has held it in 17 quarters since. The position peaked at $5.42M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Citadel Advisors held 32,504 shares of iRadimed worth $3.13M as of Q1 2026.
  • Citadel Advisors sold 23,254 iRadimed shares in Q1 2026, an estimated $2.33M.
  • iRadimed made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5185 holding.
  • Citadel Advisors first reported a position in iRadimed in Q1 2020 and has held it in 17 quarters since.
  • Citadel Advisors's iRadimed position peaked at $5.42M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.